Raymond James Trust N.A. Regeneron Pharmaceuticals, Inc. Transaction History
Raymond James Trust N.A.
- $4.55 Billion
- Q3 2024
A detailed history of Raymond James Trust N.A. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Raymond James Trust N.A. holds 1,064 shares of REGN stock, worth $777,039. This represents 0.02% of its overall portfolio holdings.
Number of Shares
1,064
Previous 1,034
2.9%
Holding current value
$777,039
Previous $1.09 Million
2.95%
% of portfolio
0.02%
Previous 0.03%
Shares
30 transactions
Others Institutions Holding REGN
# of Institutions
1,532Shares Held
83.6MCall Options Held
1.22MPut Options Held
1.51M-
Vanguard Group Inc Valley Forge, PA9.32MShares$6.81 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$6.17 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.49MShares$5.47 Billion0.64% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.58 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$3.14 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $78.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...